Research & Development
With an ever increasing demand of effective care as well as a growing global awareness of healthcare efficiency and costs, improved diagnostic tools offer a unique opportunity for:
- Earlier detection and better characterization of diseases
- Determining the right therapy at the right dose for a patient (precision medicine)
- Monitoring therapy response
As a global leader in the field of radiopharmaceuticals, Life Molecular Imaging is developing a product portfolio of innovative molecular imaging probes that address major clinical needs in neurology, oncology, and cardiology.
LMI is supporting use of imaging biomarkers in several major therapeutic trials in Alzheimer’s disease.